Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02034409 · ClinicalTrials.gov registry record · Phase 1
A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis
A Phase 1 study of Osteoarthritis, Degenerative, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 140
- Enrollment target
- 3
- Study locations
NCT02034409 is a Phase 1 study of Osteoarthritis, Degenerative that has completed, run by VA Office of Research and Development. The registered enrollment target is 140 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT02034409, a Phase 1 study of Osteoarthritis, Degenerative, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 140 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this exploratory trial is to investigate whether PLIUS is potentially effective as a disease and symptom modifying intervention in patients with early knee OA.
Conditions Studied
Interventions
- DEVICE Sham Comparator
- DEVICE Pulsed Low Intensity Ultrasound
Study Locations (3)
California
- VA San Diego Healthcare System, San Diego, CA - San Diego
Texas
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX - Dallas
Utah
- VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2015-05-22 |
| Est. Completion | 2020-09-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02034409
The ClinicalTrials.gov registry entry for NCT02034409 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis, Degenerative appearing as the primary indexed condition, and to 2 interventions - of which Sham Comparator is the first listed.
NCT02034409 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Texas, Utah.
Frequently Asked Questions
What is clinical trial NCT02034409 about?
NCT02034409 is a clinical study titled "A Pilot Trial to Assess Low-Intensity Ultrasound in Osteoarthritis". The purpose of this exploratory trial is to investigate whether PLIUS is potentially effective as a disease and symptom modifying intervention in patients with early knee OA.
What is the current status of trial NCT02034409?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 140 participants. The study started on 2015-05-22. Estimated completion is 2020-09-30.
What conditions does trial NCT02034409 study?
This clinical trial studies the following conditions: Osteoarthritis, Degenerative.
What interventions are being tested in trial NCT02034409?
The interventions under investigation include: Sham Comparator (DEVICE), Pulsed Low Intensity Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT02034409?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02034409 being conducted?
This trial has 3 study locations across California, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.